Published in J Infect Dis on July 15, 2010
Human pathogenic hantaviruses and prevention of infection. Hum Vaccin (2011) 1.40
Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerg Infect Dis (2010) 0.99
Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment. Clin Microbiol Infect (2013) 0.93
The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster. Immunology (2013) 0.91
Multiplex Analysis of Serum Cytokines in Humans with Hantavirus Pulmonary Syndrome. Front Immunol (2015) 0.84
Vascular events in viral hemorrhagic fevers: a comparative study of dengue and hantaviruses. Cell Tissue Res (2014) 0.83
The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome. Virulence (2013) 0.83
Impact of the Yosemite hantavirus outbreak on hantavirus antibody testing at a national reference laboratory. Clin Vaccine Immunol (2013) 0.83
Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. PLoS Negl Trop Dis (2013) 0.80
Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure. PLoS Negl Trop Dis (2015) 0.78
Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airways. PLoS Pathog (2017) 0.75
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis (2007) 6.46
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07
Viral discovery and sequence recovery using DNA microarrays. PLoS Biol (2003) 5.95
Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol (2004) 5.86
Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis (2004) 5.49
Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science (2004) 5.49
Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42
Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis (2004) 4.83
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56
A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med (2012) 4.15
Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05
Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis (2003) 4.02
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01
Marburg virus infection detected in a common African bat. PLoS One (2007) 4.01
High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis (2007) 3.74
Discovery of swine as a host for the Reston ebolavirus. Science (2009) 3.68
Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis (2006) 3.65
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38
An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg Infect Dis (2002) 3.36
Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35
Rift Valley fever virus. J Am Vet Med Assoc (2009) 3.22
Bat Nipah virus, Thailand. Emerg Infect Dis (2005) 3.22
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol (2004) 3.04
Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Emerg Infect Dis (2002) 2.89
Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis (2006) 2.85
Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis (2009) 2.82
Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol (2003) 2.75
Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis (2009) 2.73
Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis (2005) 2.62
Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis (2003) 2.61
Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia. Emerg Infect Dis (2002) 2.50
Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol (2006) 2.39
Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol (2002) 2.36
New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol (2002) 2.35
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog (2008) 2.23
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis (2003) 2.22
Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg Infect Dis (2010) 2.22
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog (2010) 2.18
Successful topical respiratory tract immunization of primates against Ebola virus. J Virol (2007) 2.06
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00
Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. J Virol (2008) 1.93
Clinical presentation of nipah virus infection in Bangladesh. Clin Infect Dis (2008) 1.91
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol (2015) 1.91
Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003. Emerg Infect Dis (2005) 1.81
Hantavirus pulmonary syndrome--United States: updated recommendations for risk reduction. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 1.77
Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis (2004) 1.76
Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis (2010) 1.75
Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J Virol (2012) 1.74
Framework for leadership and training of Biosafety Level 4 laboratory workers. Emerg Infect Dis (2008) 1.66
Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J Clin Microbiol (2007) 1.64
Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis (2007) 1.63
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62
Antibody-dependent enhancement of Ebola virus infection. J Virol (2003) 1.62
Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia. Emerg Infect Dis (2002) 1.61
Ebola Reston virus infection of pigs: clinical significance and transmission potential. J Infect Dis (2011) 1.58